| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/05/2000 | EP1015011A1 Peptide nucleic acids having antibacterial activity |
| 07/05/2000 | EP1015005A1 Gene transfer with adenoviruses having modified fiber proteins |
| 07/05/2000 | EP1015003A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 07/05/2000 | EP1014790A1 Chemical modification of dna using peptide nucleic acid conjugates |
| 07/05/2000 | EP0853487B1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/05/2000 | EP0831923A4 Separation of active complexes |
| 07/05/2000 | CN2385727Y Genetransfer device |
| 07/05/2000 | CN1259165A Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 07/05/2000 | CN1259134A Novel class of nucleic acid cationic transfecting agents |
| 07/04/2000 | US6084090 Human papilloma virus anti-sense oligonucleotides |
| 07/04/2000 | US6084085 Inducing resistance to tumor growth with soluble IGF-1 receptor |
| 07/04/2000 | US6084084 Nucleotide and amino acid sequences; for anticonvulsants, neuroprotectants, analgesics and cognition enhancers; for diagnosis and therapy of related nervous system disorders |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6084071 Nucleotide and amino acid sequences of chemokine produced by culturing cell transformed with vector and purifying produced protein; for prevention and therapy of related diseases |
| 07/04/2000 | US6084060 Amino acid sequence of protein that inhibits differentiation of progenitor cells; for expanding progenitor cell populations ex vivo to increase chances of engraftation and gene therapy |
| 07/04/2000 | US6083924 DnaB of staphylococcus aureus |
| 07/04/2000 | US6083905 Method and means for detecting and treating disorders in the blood coagulation cascade |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083750 Adenovirus vectors |
| 07/04/2000 | US6083749 DNA encoding a human serotonin receptor (5-HT4B) and uses thereof |
| 07/04/2000 | US6083746 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083745 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083741 Nucleotide sequences linked to regulatory sequences which code a peptide or protein; for efficient transfer of nuucleotide sequences into cells; for gene therapy |
| 07/04/2000 | US6083732 Biologically active alternative form of the ikkaα IκB kinase |
| 07/04/2000 | US6083720 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 07/04/2000 | US6083719 Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 07/04/2000 | US6083716 Chimpanzee adenovirus vectors |
| 07/04/2000 | US6083703 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes |
| 07/04/2000 | US6083702 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 07/04/2000 | US6083523 Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products |
| 07/04/2000 | US6082364 Pluripotential bone marrow cell line and methods of using the same |
| 06/30/2000 | CA2256123A1 A novel hypertension related calcium regulated gene (hcarg) |
| 06/29/2000 | WO2000037685A2 Method of identifying a psychotropic agent using differential gene expression |
| 06/29/2000 | WO2000037664A1 Method for preparing suspension of stable posiplexes |
| 06/29/2000 | WO2000037659A1 Non-viral transfection vector |
| 06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | WO2000037640A2 Compositions and methods for the treatment of tumor |
| 06/29/2000 | WO2000037635A2 Genetic suppressor elements against human immunodeficiency virus |
| 06/29/2000 | WO2000037634A2 Novel polypeptides and nucleic acids encoding same |
| 06/29/2000 | WO2000037613A2 Human akt-3 |
| 06/29/2000 | WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE |
| 06/29/2000 | WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 06/29/2000 | WO2000037608A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 06/29/2000 | WO2000037498A1 THE POLYPEPTIDE DREAM, USED AS Ca2+IONS-DEPENDENT TRANSCRIPTIONAL REGULATOR AND ITS GENE CODING THEREFOR |
| 06/29/2000 | WO2000037494A2 Chlamydia trachomatis antigens |
| 06/29/2000 | WO2000037493A2 Type iii secretion system antigens from bordetella pertussis |
| 06/29/2000 | WO2000037113A1 11 cby genomic sequence |
| 06/29/2000 | WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | WO2000037111A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 06/29/2000 | WO2000037095A1 Cardiac muscle function and manipulation |
| 06/29/2000 | WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/29/2000 | WO2000037051A1 Aerosol formulations for buccal and pulmonary application |
| 06/29/2000 | WO2000037046A1 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 06/29/2000 | WO2000036919A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 06/29/2000 | WO2000036909A2 In vivo odontogenic model using rodent's mandibular incisor |
| 06/29/2000 | WO2000014262A3 Methylation of plasmid vectors |
| 06/29/2000 | WO2000012683A3 Stem cells bearing an fgf receptor on the cell surface |
| 06/29/2000 | WO2000012118A3 Inhibiting cardiomyocyte death |
| 06/29/2000 | WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions |
| 06/29/2000 | WO2000008145A3 Novel genes in control of hematopoiesis |
| 06/29/2000 | WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 06/29/2000 | WO2000004876A3 Controlled release of bioactive substances |
| 06/29/2000 | WO1999055854A3 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/29/2000 | WO1998050067A3 Use or a secretion vector for fertility control by oral vaccination |
| 06/29/2000 | DE19859056A1 New nucleic acids that inhibit expression of the CD30 antigen or ribosomal kinase rsk3, for modulating activity of, or killing, cells expressing these proteins, e.g. tumor cells |
| 06/29/2000 | CA2395595A1 In vivo model for experimental manipulation of calcified tissues and associated soft tissues |
| 06/29/2000 | CA2371289A1 Novel polypeptides and nucleic acids encoding same |
| 06/29/2000 | CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 06/29/2000 | CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | CA2356764A1 Type iii secretion system antigens from bordetella pertussis |
| 06/29/2000 | CA2356244A1 Somatic cells with ablated prp gene and methods of use |
| 06/29/2000 | CA2355882A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 06/29/2000 | CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | CA2355876A1 Chlamydia trachomatis antigens |
| 06/29/2000 | CA2355836A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/29/2000 | CA2355696A1 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 06/29/2000 | CA2355228A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 06/29/2000 | CA2354074A1 Method of identifying a psychotropic agent using differential gene expression |
| 06/29/2000 | CA2354030A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 06/29/2000 | CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/29/2000 | CA2353790A1 Non-viral transfection vector |
| 06/29/2000 | CA2353775A1 Compositions and methods for the treatment of tumor |
| 06/29/2000 | CA2352535A1 Method for preparing suspension of stable posiplexes |
| 06/28/2000 | EP1013772A1 Method for preparing suspension of stable posiplexes |
| 06/28/2000 | EP1013770A1 Non-viral transfection vector |
| 06/28/2000 | EP1013757A2 Attenuated forms of bovine viral diarrhea virus |
| 06/28/2000 | EP1013665A1 Novel polypeptide having water channel activity and dna sequence |
| 06/28/2000 | EP1013661A1 Novel bicyclonucleoside and oligonucleotide analogues |
| 06/28/2000 | EP1013288A2 Erythropoietin in the treatment of domestic and livestock animals for anemia |
| 06/28/2000 | EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/28/2000 | EP1012603A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 06/28/2000 | EP1012333A1 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23 |
| 06/28/2000 | EP1012331A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 06/28/2000 | EP1012321A2 Viral infection of cells using viral vectors |
| 06/28/2000 | EP1012317A2 Hypoxia inducible promoter |
| 06/28/2000 | EP1012313A1 INTRACELLULAR INHIBITORS OF Gq PROTEIN SIGNALING |
| 06/28/2000 | EP1012300A1 Hnk-1 sulfotransferase and methods of use therefor |
| 06/28/2000 | EP1012295A1 Alphavirus rna replicon systems |
| 06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 06/28/2000 | EP1012291A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |